69 results
8-K
EX-4.1
UBX
Unity Biotechnology Inc
13 Nov 23
UNITY Biotechnology Announces Exercise of Warrants for $4.38 Million in Gross Proceeds
7:00am
otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving
8-K
UBX
Unity Biotechnology Inc
13 Nov 23
UNITY Biotechnology Announces Exercise of Warrants for $4.38 Million in Gross Proceeds
7:00am
Letter is expected to occur on or about November 14, 2023 (the “Closing Date”), subject to satisfaction of customary closing conditions. The Company
8-K
EX-99.1
UBX
Unity Biotechnology Inc
13 Nov 23
UNITY Biotechnology Announces Exercise of Warrants for $4.38 Million in Gross Proceeds
7:00am
to satisfaction of customary closing conditions. The Company believes that together with these proceeds, the Company’s current cash, cash equivalents … . Such statements include, but are not limited to, statements related to the timing and completion of the offering, the satisfaction of customary closing
8-K
EX-10.1
2agnddsu6rk
13 Nov 23
UNITY Biotechnology Announces Exercise of Warrants for $4.38 Million in Gross Proceeds
7:00am
424B5
qsr41fnn0n
25 Oct 22
Prospectus supplement for primary offering
9:39pm
8-K
EX-99.1
tfy iw9g7
22 Aug 22
UNITY Biotechnology Announces Pricing of Upsized Underwritten Public Offering
4:13pm
8-K
EX-4.1
rchd82bw4 r67lqb4fzd
22 Aug 22
UNITY Biotechnology Announces Pricing of Upsized Underwritten Public Offering
4:13pm
8-K
EX-1.1
kft vd2lpgdg0b96
22 Aug 22
UNITY Biotechnology Announces Pricing of Upsized Underwritten Public Offering
4:13pm
424B5
dno277
19 Aug 22
Prospectus supplement for primary offering
8:42am